• Bandeau Investisseurs

Key annual figures from 2012 to 2020

Balance sheet assets...

In EUR millions 2020 2019 2018 2017* 2017 2016 2015 2014 2013 2012
Goodwill 24.15 24.15 24.15 24.53 24.53 21.67 21.67 21.79 21.79 21.79
Non-current assets 190.28 194.42 161.70 130.98 117.83 110.33 104.00 95.73 92.51 90.53
Current assets 366.42 372.37 354.17 298.29 296.77 252.79 234.39 208.78 181.18 167.74
Inventory 149.56 161.13 136.05 108.90 107.37 93.78 90.73 76.70 73.62 71.77
Receivables 141.36 140.22 150.26 125.06 125.06 118.38 109.32 97.07 81.96 76.30
Other receivables and cash 75.49 71.01 67.86 64.33 64.33 40.64 34.34 35.01 25.60 19.67

* figures restated for IFRS 15

 Balance sheet liabilities...

In EUR millions 2020 2019 2018 2017* 2017 2016 2015 2014 2013 2012
Shareholders'equity 116.08 140.38 132.82 127.45 127.45 125.24 111.00 95.02 81.11 72.16
Financial liabilities 256.22 240.53 205.60 157.64 157.64 121.97 121.03 106.93 98.44 99.88
Total liabilities and shareholders' equity 556.70 566.79 515.87 429.27 414.60 363.12 338.39 304.51 273.69 258.27

 * figures restated for IFRS 15

Income statement...

In EUR millions 2020 2019 2018 2017* 2017 2016 2015 2014 2013 2012
Sales 438.59 520.41 476.52 433.32 436.13 431.65 381.21 339.89 303.66 289.11
Payroll charges 119.95 123.13 110.19 102.85 107.42 103.82 94.80 88.11 84.24 82.72
Operating profit -6.85 16.27 9.58 19.80 19.80 26.36 19.75 21.35 16.43 10.37
Net income -19.44 8.72 9.19 8.51 8.51 21.28 16.16 15.13 10.92 4.13

* figures restated for IFRS 15

 Other indicators...

In EUR millions 2020 2019 2018 2017* 2017 2016 2015 2014 2013 2012
Staff 3 718 3 854 3 697 3 459 3 459 3 268 3 067 2 762 2 680 2 768
Research & development 75.96 83.19 80.98 66.95 66.95 56.80 52.52 48.07 45.36 46.35
EBITDA excl. hedging instrument **
24.20 45.75 29.50 37.63  35.63 42.54  33.00  33.66  26.38  19.87 

* figures restated for IFRS 15

** Net income+taxation+impairment of goodwill+interest and finance costs+depreciation charge

 Ratios...

Percentage 2020 2019 2018 2017* 2017 2016 2015 2014 2013 2012
Payroll charges /sales 27% 24% 23% 24% 25% 24% 25% 26% 28% 29%
Net income / sales -4% 2% 2% 2% 2% 5% 4% 4% 4% 1%
Net income / shareholders' equity -17% 6% 7% 7% 7% 17% 15% 16% 13% 6%
Research & development / sales 17% 16% 17% 15% 15% 13% 14% 14% 15% 16%
Bookmark and Share